Austrian sensor expert AMS adopts spectral sensing technology to rapid test for COVID-19 disease

Wireless sensing technologies have been wide used to prevent the spread of COVID-19 virus. Several solutions used LiDAR sensors to keep social distancing or to control people flow . Spectral sensing is another technology that is appliedfor medical testing for COVID-19 infection. Austrian sensor expert AMS had announced its cooperation with two German medical companies for such applications.

AMS is supplying its AS7341L spectral sensor to midge medical, a German medical technology startup from Berlin, to develop a disruptive technology for science-backed rapid genetic and blood test at home or in hospital at a lower cost. The spectral sensor of AMS will be used to establish a sensor system that allows spectral display of amplified COVID-19 (SARS-CoV-2) virus particles.

In last June, AMS also worked with Senova who produces vitro diagnostic medical devices in Germany. The two companies have successfully finished tests using a combination of Senova technology and AMS spectral sensor technology to improve performance and usability of a lateral flow-based test so to detect antibodies concerning the COVID-19 (SARS-CoV-2) virus.

Recent experiments proved feasibility of quantitative detection of serum proteins . This is more than a factor of 10 more sensitive than the detection achieved with most of the standard rapid test read-out devices. Along with COVID-19 (SARS-CoV-2) antigen assays, this provides the platform for COVID-19 (SARS-CoV-2) virus detection in saliva and nasal swab samples in the early stage of COVID-19 (SARS-CoV-2).

To meet mass production scale faster, AMS will cooperate with Jabil Healthcare to integrate its sensor technology into a high-volume turnkey module that allows for a Bluetooth connection.